Literature DB >> 26855069

Characterization of 5α-reductase activity and isoenzymes in human abdominal adipose tissues.

Mohamed Fouad Mansour1, Mélissa Pelletier2, André Tchernof3.   

Abstract

INTRODUCTION: The substrate for the generation of 5α-dihydrotestosterone (DHT) is either androstenedione (4-dione) which is first converted to androstanedione and then to DHT through 17-oxoreductase activity, or testosterone, which is directly converted to DHT. Three 5α-reductase isoenzymes have been characterized and designated as types 1, 2 and 3 (SRD5A1, 2 and 3).
OBJECTIVE: To define the predominant source of local DHT production in human adipose tissues, identify 5α-reductase isoenzymes and test their impact on preadipocyte differentiation.
METHODS: Cultures of omental (OM) and subcutaneous (SC) preadipocytes were treated for 0, 6 or 24h with 30nM (14)C-4-dione or (14)C-testosterone, with and without 500nM 5α-reductase inhibitors 17-N,N-diethylcarbamoyl-4-methyl-4-aza-5-androstan-3-one (4-MA) or finasteride. Protein level and mRNA abundance of 5α-reductase isoenzymes/transcripts were examined in whole SC and OM adipose tissue. HEK-293 cells stably transfected with 5α-reductase type 1, 2 or 3 were used to test 5α-reductase inhibitors. We also assessed the impact of 5α-reductase inhibitors on preadipocyte differentiation.
RESULTS: Over 24h, DHT formation from 4-dione increased gradually (p<0.05) and was significantly higher compared to that generated from testosterone (p<0.001). DHT formation from both 4-dione and testosterone was blocked by both 5α-reductase inhibitors. In whole adipose tissue from both fat compartments, SRD5A3 was the most highly expressed isoenzyme followed by SRD5A1 (p<0.001). SRD5A2 was not expressed. In HEK-293 cells, 4-MA and finasteride inhibited activity of 5α-reductases types 2 and 3 but not type 1. In preadipocyte cultures where differentiation was inhibited by 4-dione (p<0.05, n=7) or testosterone (p<0.05, n=5), the inhibitors 4-MA and finasteride abolished these effects.
CONCLUSION: Although 4-dione is the main source of DHT in human preadipocytes, production of this steroid by 5α-reductase isoenzymes mediates the inhibitory effect of both 4-dione and testosterone on preadipocyte differentiation.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  5α-reductase; Adipose tissue; Androstenedione; Dihydrotestosterone; Testosterone

Mesh:

Substances:

Year:  2016        PMID: 26855069     DOI: 10.1016/j.jsbmb.2016.02.003

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  5 in total

Review 1.  Current physico-biochemistry in steroid research and status of structural biology for steroid-converting enzymes.

Authors:  S X Lin; R Shi; X J Hu; T M Penning
Journal:  J Steroid Biochem Mol Biol       Date:  2016-05-16       Impact factor: 4.292

2.  Androgen Receptor (AR) Gene (CAG)n and (GGN)n Length Polymorphisms and Symptoms in Young Males With Long-Lasting Adverse Effects After Finasteride Use Against Androgenic Alopecia.

Authors:  Sabina Cauci; Giovanni Chiriacò; Erika Cecchin; Giuseppe Toffoli; Serena Xodo; Giuseppe Stinco; Carlo Trombetta
Journal:  Sex Med       Date:  2016-12-23       Impact factor: 2.491

Review 3.  Depression and obesity: evidence of shared biological mechanisms.

Authors:  Yuri Milaneschi; W Kyle Simmons; Elisabeth F C van Rossum; Brenda Wjh Penninx
Journal:  Mol Psychiatry       Date:  2018-02-16       Impact factor: 15.992

4.  Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride.

Authors:  Tina Kiguradze; William H Temps; Steven M Belknap; Paul R Yarnold; John Cashy; Robert E Brannigan; Beatrice Nardone; Giuseppe Micali; Dennis Paul West
Journal:  PeerJ       Date:  2017-03-09       Impact factor: 2.984

Review 5.  Depression and Obesity: Analysis of Common Biomarkers.

Authors:  Walter Milano; Paola Ambrosio; Francesca Carizzone; Valeria De Biasio; Walter Di Munzio; Maria Gabriella Foia; Anna Capasso
Journal:  Diseases       Date:  2020-06-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.